Category
Pharmaceuticals
-
•
Foreign trial data used in 4/5 of approved drugs
FairWarning’s Lea Yu and The New York Times‘ Gardiner Harris drew our attention to a report from the HHS Office…
-
Pharma starts disclosing sample numbers
The Health Policy law will require drug makers to disclose the amounts of free samples they distribute, a requirement which…
-
•
Factory that made recalled Tylenol was cited
The U.S. House of Representatives’ oversight committee will hold a hearing today about an April 30 recall of children’s Tylenol…
-
•
Study authors don’t always have access to raw data
John Fauber of the Milwaukee Journal Sentinel reports on outside authors of drug company-funded studies who do not have access…
-
•
Drug companies hit with punitive damages
A jury has decided Teva Parenteral Medicines and Baxter Healthcare Corp. must pay a combined $500 million in punitive damages…
-
•
Newly released data reveals inappropriate use of antipsychotics in nursing homes
Kay Lazar and Matt Carroll of The Boston Globe have written about nursing homes that use “antipsychotic drugs to control…
-
•
PR specialist: Health journalists have critical role
Health journalists may be surprised to find support from Paul Oestreicher, a marketing communications consultant and adjunct professor at New…
-
•
Feds take aim at off-label marketing
The Wall Street Journal‘s Jeanne Whalen writes that a recent string of charges against drug companies, including heavyweights like Pfizer,…
-
•
Drug data could inform stories about elder care
The 2007 National Home and Hospice Care Survey (NHHCS ) Medication Public-Use File and Documentation are now available for downloading.…
-
•
Joint Commission finds improved hospital quality
The latest report from The Joint Commission, a hospital accrediting organization, finds that “overall, hospitals are following evidence-based standards for…